Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Therapeutic Effects of Mesenchymal Stem Cell (Mscs) Exosomes in Covid-19 Disease; Focusing on Dexamethasone Therapy Publisher Pubmed



Derafsh E1 ; Ebrahimzadeh F2 ; Kahrizi MS3 ; Kayedi M4 ; Shojaei N5 ; Rahimi S6 ; Alesaeidi S7 ; Ghafouri K8
Authors

Source: Pathology Research and Practice Published:2023


Abstract

The study of diseases, specifically their aetiologies, their step-by-step progressions (pathogenesis), and their impact on normal structure and function, is the focus of pathology, a branch of science and medicine. In therapeutic fields, it is critical to decrease significantly elevated levels of proinflammatory cytokines. The immunomodulatory drugs such as dexamethasone have been used in several of inflammatory diseases such as Covid-19. The use of dexamethasone alone or in combination with other drugs or method such as mesenchymal stem cell (MSC) is one of the most up-to-date discussions about Covid-19. In this review, we first examined the effects of dexamethasone as monotherapy on inflammatory cytokines and then examined studies that used combination therapy of dexamethasone and other drugs such as Baricitinib, Tofacitinib and tocilizumab. Also, therapeutic aspects of MSCs are examined in this review. © 2023 Elsevier GmbH
Related Docs
View other Related Docs
1. The Role of Mesenchymal Stromal Cells in Immune Modulation of Covid-19: Focus on Cytokine Storm, Stem Cell Research and Therapy (2020)
2. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe Covid-19 Patients, Current Stem Cell Research and Therapy (2024)
3. The Critical Role of Mesenchymal Stromal/Stem Cell Therapy in Covid-19 Patients: An Updated Review, Cell Biochemistry and Function (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Babak Arjmand (2)
Other Related Docs
4. Mesenchymal Stem Cell Therapies for Covid-19: Current Status and Mechanism of Action, Life Sciences (2020)
5. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
6. Mesenchymal Stromal/Stem Cells (Mscs) and Msc-Derived Extracellular Vesicles in Covid-19-Induced Ards: Mechanisms of Action, Research Progress, Challenges, and Opportunities, International Immunopharmacology (2021)
7. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
8. Mesenchymal Stem/Stromal Cells As a Valuable Source for the Treatment of Immune-Mediated Disorders, Stem Cell Research and Therapy (2021)
9. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
10. Stem Cell Therapy Potency in Personalizing Severe Covid-19 Treatment, Stem Cell Reviews and Reports (2021)
11. Human Placenta-Derived Mesenchymal Stem Cells Transplantation in Patients With Acute Respiratory Distress Syndrome (Ards) Caused by Covid-19 (Phase I Clinical Trial): Safety Profile Assessment, Stem Cell Research and Therapy (2022)
12. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
13. The Use of Mesenchymal Stem Cells in the Process of Treatment and Tissue Regeneration After Recovery in Patients With Covid-19, Gene (2021)
14. Towards Treatment Planning of Covid-19: Rationale and Hypothesis for the Use of Multiple Immunosuppressive Agents: Anti-Antibodies, Immunoglobulins, and Corticosteroids, International Immunopharmacology (2020)
15. Cell Therapy in Patients With Covid-19 Using Wharton’S Jelly Mesenchymal Stem Cells: A Phase 1 Clinical Trial, Stem Cell Research and Therapy (2021)
16. Critical Roles of Cytokine Storm and Bacterial Infection in Patients With Covid-19: Therapeutic Potential of Mesenchymal Stem Cells, Inflammopharmacology (2023)
17. Covid-19 Associated Thrombotic Thrombocytopenic Purpura (Ttp); a Case Series and Mini-Review, International Immunopharmacology (2021)
18. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
19. Conquering the Cytokine Storm in Covid-19-Induced Ards Using Placenta-Derived Decidua Stromal Cells, Journal of Cellular and Molecular Medicine (2021)
20. Therapeutic Potentials and Candidates for Covid-19, Iranian Journal of Science (2023)